case-study-page
knowledge

Retinal Screening That Goes Beyond Diabetic Retinopathy

""

What if a retinal image could reveal more than just diabetic retinopathy?

With the Welch Allyn RetinaVue care delivery model, Baxter provides
board-certified, state-licensed eye specialists in all 50 states who
can detect can detect up to 30 vision conditions including
vision threatening pathologies including:

  • Diabetic Retinopathy
  • Clinically Significant Macular Edema (CSME)
  • Age-Related Macular Degeneration (AMD)
  • Glaucoma
  • Retinal Detachment
  • Corneal Abrasion

 

Discover what a single retinal image can reveal.

Download our new informational one-pager.

Discover How RETINAVUE Can Help Detect Vision Conditions - Including Vision-Threatening Pathologies and Protect Patient Vision

This helps clinicians identify serious eye disease early so they can develop timely treatment decisions and care plans that support preserving patients’ vision.

With a single exam, it offers a simple, fast way to help elevate care, close care gaps, and improve outcomes for patients living with diabetes in point-of-care settings.

Learn how your healthcare organization can help preserve vision in patients living with diabetes by connecting with a Baxter Vision consultant.

  

Learn more about the RETINAVUE
care delivery model.

Rx Only: For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.

All clinical interpretations are performed by a licensed ophthalmologist.

Baxter, Hillrom, RetinaVue and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries. US-FLC147-250057 (v3.0) 03/2026